Clindamycin hydrochloride
![Clindamycin hydrochloride Structure](CAS/GIF/21462-39-5.gif)
- CAS No.
- 21462-39-5
- Chemical Name:
- Clindamycin hydrochloride
- Synonyms
- CLINDAMYCIN HCL;ClindaMycin-d3;CLEOCIN;Dalacin;7(S)-CHLORO-7-DEOXYLINCOMYCIN;Clindamycin hydrochloride, nonsterile;U-21251F;dalacina;Dalacin S;Clidamacin
- CBNumber:
- CB2398837
- Molecular Formula:
- C18H34Cl2N2O5S
- Molecular Weight:
- 461.44
- MOL File:
- 21462-39-5.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/26 16:29:23
Melting point | 141°C |
---|---|
storage temp. | 2-8°C |
solubility | H2O: 50 mg/mL, clear, colorless |
form | Solid |
color | White to Off-White |
BRN | 4070786 |
Stability | Hygroscopic |
InChIKey | AUODDLQVRAJAJM-XJQDNNTCSA-N |
SMILES | [C@@H]1([C@@H]([C@H](C)Cl)NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](O)[C@H](O)[C@H]([C@@H](SC)O1)O.Cl |&1:0,1,2,8,10,17,19,21,22,r| |
CAS DataBase Reference | 21462-39-5(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H317-H319-H362 |
Precautionary statements | P260-P263-P280-P302+P352-P305+P351+P338-P308+P313 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36-37/39 |
WGK Germany | 2 |
RTECS | GF2275000 |
F | 10 |
HS Code | 29419000 |
Clindamycin hydrochloride price More Price(6)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | C5269 | Clindamycin hydrochloride lincosamide antibiotic | 21462-39-5 | 10MG | ₹8789.9 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | C5269 | Clindamycin hydrochloride lincosamide antibiotic | 21462-39-5 | 50MG | ₹21054.63 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | C5269 | Clindamycin hydrochloride lincosamide antibiotic | 21462-39-5 | 100MG | ₹33514.2 | 2022-06-14 | Buy |
ottokemi | C 6326 | Clindamycin hydrochloride | 21462-39-5 | 10mg | ₹8001 | 2022-05-26 | Buy |
ottokemi | C 6326 | Clindamycin hydrochloride | 21462-39-5 | 50mg | ₹24039 | 2022-05-26 | Buy |
Clindamycin hydrochloride Chemical Properties,Uses,Production
Chemical Properties
White Solid
Uses
Clindamycin hydrochloride is a salt of clindamycin, a semi-synthetic lincosamide. The hydrochloride salt forms at the basic N-ethylproline moiety and is the preferred pharmaceutical formulation. Like other members of the lincosamide family, clindamycin is a broad spectrum antibiotic with activity against anaerobic bacteria and protozoans. Clindamycin hydrochloride acts by binding to the 23S ribosomal subunit, blocking protein synthesis. Clindamycin hydrochloride has been extensively studied with over 8,000 literature citations.
General Description
Chemical structure: macrolide
Contact allergens
This lincosanide antibiotic is used in topical form for acne, or systemically has been responsible for exanthematous rashes and acute generalized exanthematous pustulosis.
Clinical Use
Clindamycin is recommended for the treatment of a widevariety of upper respiratory, skin, and tissue infections causedby susceptible bacteria. Its activity against streptococci,staphylococci, and pneumococci is indisputably high, and it isone of the most potent agents available against somenon–spore-forming anaerobic bacteria, the Bacteroides spp.in particular. An increasing number of reports of clindamycin-associated GI toxicity, which range in severity fromdiarrhea to an occasionally serious pseudomembranous colitis,have, however, caused some clinical experts to call for areappraisal of the role of this antibiotic in therapy.Clindamycin- (or lincomycin)-associated colitis may be particularlydangerous in elderly or debilitated patients and hascaused deaths in such individuals. The colitis, which is usuallyreversible when the drug is discontinued, is now believedto result from an overgrowth of a clindamycin-resistant strainof the anaerobic intestinal bacterium Clostridium difficile.229The intestinal lining is damaged by a glycoprotein endotoxinreleased by lysis of this organism.
The glycopeptide antibiotic vancomycin has been effectivein the treatment of clindamycin-induced pseudomembranouscolitis and in the control of the experimentally induced bacterial condition in animals. Clindamycin shouldbe reserved for staphylococcal tissue infections, such as cellulitisand osteomyelitis, in penicillin-allergic patients andfor severe anaerobic infections outside the central nervoussystem. Ordinarily, it should not be used to treat upper respiratorytract infections caused by bacteria sensitive to othersafer antibiotics or in prophylaxis.
Clindamycin hydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CHEMXTREE STANDARDS | +919872732255 | Punjab, India | 96 | 58 | Inquiry |
Vivimed Labs Ltd | +914066086608 | Telangana, India | 61 | 58 | Inquiry |
Alfa Omega Pharma | +91-8050045945 +91-9972665399 | Maharashtra, India | 126 | 58 | Inquiry |
aistrifarma | +91-6374274350 +91-7708086868 | Tamil Nadu, India | 15 | 58 | Inquiry |
Synthink Research Chemicals | 09158051123 | Pune, India | 398 | 58 | Inquiry |
Medvance Solution | 91-9000487586 | Hyderabad, India | 137 | 58 | Inquiry |
Kebee Pharmachemie Pvt., Ltd. | 91-22-28328669 | Maharashtra, India | 65 | 58 | Inquiry |
Eastern Chemicals (Mumbai) Pvt., Ltd. | 91-22-67365900 | Maharashtra, India | 104 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
Maas Pharma Chemicals | +91-9958666224 | Delhi, India | 1607 | 58 | Inquiry |
Supplier | Advantage |
---|---|
CHEMXTREE STANDARDS | 58 |
Vivimed Labs Ltd | 58 |
Alfa Omega Pharma | 58 |
aistrifarma | 58 |
Synthink Research Chemicals | 58 |
Medvance Solution | 58 |
Kebee Pharmachemie Pvt., Ltd. | 58 |
Eastern Chemicals (Mumbai) Pvt., Ltd. | 58 |
Pharma Affiliates | 58 |
Maas Pharma Chemicals | 58 |
Related articles
- Clindamycin Hydrochloride: Mechanisms of Action and Adverse Effects
- Clindamycin hydrochloride inhibits bacterial protein synthesis, reduces virulence, enhances neutrophil function, but requires ....
- Jul 26,2024
- Properties, pharmacological effects and clinical applications of clindamycin hydrochloride
- Clindamycin inhibits protein synthesis by acting on the 50S ribosomal subunits of bacteria. The colitis resulting from the use....
- Jul 25,2022
21462-39-5(Clindamycin hydrochloride)Related Search:
1of4
chevron_right